198 related articles for article (PubMed ID: 34797617)
21. Drugs for macular degeneration, price discrimination, and Medicare’s responsibility not to overpay.
Silver J
JAMA; 2014 Jul; 312(1):23-4. PubMed ID: 24860863
[No Abstract] [Full Text] [Related]
22. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
23. Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?
Dhruva SS; Ramachandran R; Ross JS
N Engl J Med; 2022 Oct; 387(17):1539-1541. PubMed ID: 36301560
[No Abstract] [Full Text] [Related]
24. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2004.
Johnson P
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-24. PubMed ID: 15747439
[No Abstract] [Full Text] [Related]
25. Business of Health: Business of Health Insurance.
Berry MD
Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-105. PubMed ID: 29359895
[No Abstract] [Full Text] [Related]
26. The insurance-readmission paradox: why increasing insurance coverage may not reduce hospital-level readmission rates.
Horwitz L
J Hosp Med; 2014 Nov; 9(11):743-4. PubMed ID: 25303367
[No Abstract] [Full Text] [Related]
27. The ACA and behavioral health: a look ahead.
Albright B
Behav Healthc; 2014; 34(2):36, 38-40. PubMed ID: 24864549
[No Abstract] [Full Text] [Related]
28. Benefits and services.
Raduege TJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-50. PubMed ID: 24482874
[No Abstract] [Full Text] [Related]
29. The American health care system--Medicaid.
Iglehart JK
N Engl J Med; 1999 Feb; 340(5):403-8. PubMed ID: 9929536
[No Abstract] [Full Text] [Related]
30. The other physician payment problem.
Bindman AB
JAMA; 2015 Jun; 313(21):2112-3. PubMed ID: 26034944
[No Abstract] [Full Text] [Related]
31. Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities.
Shishehbor MH; Aronow HD; Bartholomew JR; Beckman JA; Froehlich JB; Lookstein R; Misra S; Roberts AC; Rosenfield K; Jaff MR
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1181-6. PubMed ID: 27062192
[No Abstract] [Full Text] [Related]
32. Three cheers for logrolling--the demise of the SGR.
Aaron HJ
N Engl J Med; 2015 May; 372(21):1977-9. PubMed ID: 25902381
[No Abstract] [Full Text] [Related]
33. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?
Crosson FJ; Covinsky K; Redberg RF
JAMA Intern Med; 2021 Oct; 181(10):1278-1280. PubMed ID: 34254992
[No Abstract] [Full Text] [Related]
34. HINNs Inform Patients When Services Are Not Covered by Insurance.
Hosp Case Manag; 2017 Jun; 25(6):76-7. PubMed ID: 30152665
[No Abstract] [Full Text] [Related]
35. Medicaid waivers. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-10. PubMed ID: 19297677
[No Abstract] [Full Text] [Related]
36. Protecting medicare for doctors and seniors.
Frelinghuysen R
MD Advis; 2008; 1(4):16-7. PubMed ID: 21971384
[No Abstract] [Full Text] [Related]
37. An unfortunate tradition.
Swenson L
Minn Med; 2012 Jan; 95(1):34. PubMed ID: 22355910
[No Abstract] [Full Text] [Related]
38. The war on drug--prices: states are taking up the fight to reduce prescription drug costs.
Boulard G
State Legis; 2002 Mar; 28(3):12-7. PubMed ID: 11873811
[No Abstract] [Full Text] [Related]
39. Important legal, regulatory issues impacting renal care in 2008.
Riley J; Pristave R
Nephrol News Issues; 2008 Dec; 22(13):48-9. PubMed ID: 19149317
[No Abstract] [Full Text] [Related]
40. Fresh Approaches to Addressing High Drug Costs.
Armstrong J; Becker C
NCSL Legisbrief; 2019 Apr; 27(15):1-2. PubMed ID: 30990598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
